FMR1 and fragile X syndrome: In addition, pharmacogenetics testing may be used to guide the selection of medications in ASD, a technique which is also used in Down syndrome, Fragile X syndrome (FMR1 gene), and the PTEN gene mutation, which encodes a phosphatase associated with extreme macrocephaly [25].